List of insiders holdings for CymaBay Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Avoro Capital Advisors LLC Aghazadeh Behzad 10% Owner | 2024-02-14 09:09:24 | 16,337,739 0 | 16,337,739 | Form 13G |
| Versant Venture Capital II LP Versant Affiliates Fund II-A LP Versant Side Fund II LP 10% Owner | 2016-02-09 17:42:19 | 1,123,600 0 | 1,123,600 | Form 13G |
| ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC 10% Owner | 2016-02-12 17:20:33 | 1,093,100 0 | 1,093,100 | Form 13G |
| KIM DENNIS D Chief Medical Officer | 2023-04-17 19:24:09 | 472,019 0 | 472,019 | Form 4 |
| STUART LEWIS J Chief Commercial Officer | 2023-01-27 16:26:27 | 215,000 0 | 215,000 | Form 4 |
| Van Wart Harold President and CEO | 2017-01-23 18:32:29 | 200,000 0 | 200,000 | Form 4 |
| Boudes Pol F Chief Medical Officer | 2019-01-31 17:28:22 | 138,312 0 | 138,312 | Form 4 |
| Menold Daniel Vice President, Finance | 2024-01-16 19:07:39 | 135,109 0 | 135,109 | Form 4 |
| Martin Robert L. SVP, Nonclinical & Manuf. | 2018-01-26 17:09:09 | 125,000 0 | 125,000 | Form 4 |
| OMara Patrick J. SVP, Business Development | 2018-01-26 17:16:06 | 125,000 0 | 125,000 | Form 4 |
| Rosemark Kirk V.P. Regulatory & Quality | 2017-01-23 18:28:10 | 50,000 0 | 50,000 | Form 4 |
| von Emster Kurt Director | 2020-05-19 17:23:56 | 49,245 0 | 49,245 | Form 4 |
| TRUEX PAUL F Director | 2021-01-28 15:00:52 | 32,000 0 | 32,000 | Form 4 |
| Weiland Robert J. Director | 2019-01-31 17:23:35 | 27,705 0 | 27,705 | Form 4 |
| STEIN EVAN A. Director | 2019-01-31 17:22:14 | 27,705 0 | 27,705 | Form 4 |
| Booth Robert F. Director | 2019-01-31 17:19:02 | 27,705 0 | 27,705 | Form 4 |
| LANGE LOUIS G Director | 2015-06-30 18:02:55 | 9000 0 | 9000 | Form 4 |
| Kumar Hari Director | 2015-06-30 18:00:00 | 9000 0 | 9000 | Form 4 |
| PENHOET EDWARD Director | 2015-01-08 19:33:42 | 9000 0 | 9000 | Form 4 |
| Loewy Caroline M Director | 2024-03-22 17:09:21 | 0 0 | 0 | Form 4 |
| GOLDFISCHER CARL Director | 2019-02-08 20:21:09 | 0 0 | 0 | Form 4 |
| McWherter Charles President of R&D | 2024-03-22 17:06:11 | 0 0 | 0 | Form 4 |
| Lefebvre Eric Director | 2024-03-22 17:05:48 | 0 0 | 0 | Form 4 |
| Dorling Janet Director | 2024-03-22 17:03:33 | 0 0 | 0 | Form 4 |
| Shantharam Harish Chief Financial Officer | 2024-03-22 17:03:16 | 0 0 | 0 | Form 4 |
| Dickinson Klara Chief Regulatory Officer | 2024-03-22 17:02:09 | 0 0 | 0 | Form 4 |
| Quinlan Paul T General Counsel | 2024-03-22 16:59:26 | 0 0 | 0 | Form 4 |
| Wills Robert James Director | 2024-03-22 16:55:35 | 0 0 | 0 | Form 4 |
| Shah Sujal Chief Executive Officer | 2024-03-22 16:55:22 | 0 0 | 0 | Form 4 |
| WIGGANS THOMAS G Director | 2024-03-22 16:54:55 | 0 0 | 0 | Form 4 |
| EMSTER KURT VON Director | 2024-03-22 16:51:11 | 0 0 | 0 | Form 4 |